Make plans to join us in Minneapolis, Minnesota for the 2025 ACOG Annual Clinical & Scientific Meeting (ACSM) being held May 16–18. This is a must-attend event for those committed to providing exceptional obstetric and gynecologic care.
Fewer than half of young girls who experienced heavy menstrual bleeding were given hormonal treatment and far fewer were referred to gynecology, authors reported.
The findings support the potential cardiovascular advantages of the GLP-1RA class in women with PCOS, a population already at increased cardiometabolic risk.
While exercise is beneficial during pregnancy and ACOG recommends 150 mins/week, this is the first study to examine benefits of specific regimen elements on their own.
Postmenopausal women taking fezolinetant experienced positive changes in body fat distribution, increases in which are known to increase risks of cardiometabolic disease.
Details on 12 key abstracts with clinical relevance for primary care, from menopause management to PPD screening and HPV testing.
Elinzanetant reduced VMS frequency and intensity, and improved sleep and quality of life, according to the meta-analysis to be presented at the ACOG 2025 meeting.
The two areas where primary care physicians can contribute to improving women's health, according to Laurence Shields, MD.
Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.